Strategy
The Evolution of Brand Strategy
As the pharmaceutical market transforms, so does the meaning of brand strategy
Imagine being a fly on the wall when I conduct one of my research interviews in a pharmaceutical medtech or diagnostic company Observe what happens when I ask one of my carefully worded questions Please describe your brand strategy Since I research across many countries and disease areas the answers vary in detail But witness enough interviews and...
The Importance of Post-Hire Screening in the Pharmaceutical Industry
Preemployment background checks are generally wellaccepted as part of the hiring process in highlyregulated sectors such as the pharmaceutical industry With patents and other valuable intellectual propertyoften worth millionsat risk the potential of sabotage from activist groups theft from industry rivals potential insider threats and not to forget...
Biosimilars Interchangeability
Regional views aren’t interchangeable
Around the world regulators view biosimilars rather differently in terms of designating them as interchangeable with the reference product To date the US has taken a conservative approach not with standing the experience Europe has gained in monitoring thousands of patients who have switched from originator to biosimilar products Meanwhile in Asia...
Setting up a Pharmacovigilance System
Pharmacovigilance PV is principally concerned with the identification of Adverse Drug Reactions ADRs and reduction of the associated risks Detection and reporting of ADRs can make prescription of medicinal products much safer and more effective This is possible only if pharmaceutical companies and patients report the ADRs as and when they occur...
Future Prospects of Biotherapeutics and Challenges
Biotherapeutics or biological products are generally produced using living cells or organisms recombinant DNA technology controlled gene expression and antibody technologies It may be manufactured using biotechnology derived from natural sources or produced synthetically Recombinant hormones vaccines monoclonal antibody based products growth factor...
The Human-Centred Biopharma Organisation
To maximise performance it is time to put the human in the centre of the complex multicultural and dispersed ecosystem of biopharma innovation The Challenge of Sustainable Growth The Current Scenario The pharmaceutical industry has changed dramatically over the past years Despite a range of merger and acquisitions within large companies the...
Globalisation
The right steps to successfully break into a new market
Driving Forces for Globalisation As the pharmaceutical industry squares off against the challenge of globalisation there is a greater need for content than ever Driven by forces from both the clinical and commercial sides pharmaceutical companies are experiencing rising costs and competitionwhen conducting clinical trials and commercialising existi...
Life Story
The idea of product life cycle is more useful that you realise
Although its ancestral ideas can be traced back to the late th and early th centuries the concept of PLC as not at a strategic marketing tool is really the child of two later schools of thought Rogers famous Diffusion of Innovation concept with its ideas of innovators early adopter s and laggards showed how and why the adoption of innovative new pr...
China Biopharma
Is a Wave of GMP Exports in Our Future?
Its been a long road beginning with Chinas opendoor policies in the s and membership in the WTO in but Chinas recent and rapid expansion into hightech biopharma manufacturing suggests a future that will involve exports of biologics to Western markets Even before it became the worlds source of toys and electronics China had been animportant exporte...
Indian Pharma Companies Need Supply Chain Transformation
Unlocking growth
India has emerged as one of the worlds fastest growing pharmaceutical markets over the past decade The industry saw a growth of around per cent per annum between and and now stands at US billion The generic drug sector expanded at an even faster pace of per cent per annum during the same period and now accounts for per cent share of global exp...
